Literature DB >> 18795149

The Novel Retinoid, 9cUAB30, Inhibits Telomerase and Induces Apoptosis in HL60 Cells.

William K Love1, J Tyson Deangelis, Joel B Berletch, Sharla Mo Phipps, Lucy G Andrews, Wayne J Brouillette, Donald D Muccio, Trygve O Tollefsbol.   

Abstract

Telomerase, a ribonucleoprotein important to neoplastic immortality, is up-regulated in approximately 85% of cancers, including leukemias. In this study, 9cUAB30, a novel retinoic acid, resulted in differentiation of HL60 leukemia cells as indicated by morphologic changes characteristic of granulocytes. It also caused a down-regulation of hTERT gene expression and a decrease in telomerase activity. Telomerase inhibition was followed by loss of proliferative capacity, induction of apoptosis, and partial differentiation. These findings demonstrate the effectiveness of 9cUAB30 at inhibiting telomerase activity by down-regulating hTERT gene expression in human leukemic cells.

Entities:  

Year:  2008        PMID: 18795149      PMCID: PMC2533143          DOI: 10.1593/tlo.08142

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  24 in total

1.  Mechanisms for telomerase gene control in aging cells and tumorigenesis.

Authors:  T O Tollefsbol; L G Andrews
Journal:  Med Hypotheses       Date:  2001-06       Impact factor: 1.538

Review 2.  Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT).

Authors:  J C Poole; L G Andrews; T O Tollefsbol
Journal:  Gene       Date:  2001-05-16       Impact factor: 3.688

3.  Comparison of telomerase levels before and after differentiation of two cell lines of human neuroblastoma.

Authors:  C K Sanborn; A O'Connor; R S Sawin; K Moore; M J Dehart; K S Azarow
Journal:  J Surg Res       Date:  2000-10       Impact factor: 2.192

4.  Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by retinoic acids.

Authors:  S H Choi; H K Kang; E O Im; Y J Kim; Y T Bae; Y H Choi; K H Lee; H Y Chung; H K Chang; N D Kim
Journal:  Int J Oncol       Date:  2000-11       Impact factor: 5.650

5.  The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells.

Authors:  Nathan J Hansen; Rebecca C Wylie; Sharla M O Phipps; William K Love; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Int J Oncol       Date:  2007-03       Impact factor: 5.650

6.  Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.

Authors:  Clinton J Grubbs; Ronald A Lubet; Venkatram R Atigadda; Konstantin Christov; Anil M Deshpande; Vivek Tirmal; Gang Xia; Kirby I Bland; Isao Eto; Wayne J Brouillette; Donald D Muccio
Journal:  Carcinogenesis       Date:  2005-12-12       Impact factor: 4.944

Review 7.  Analysis of telomerase activity and detection of its catalytic subunit, hTERT.

Authors:  Sabita N Saldanha; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Anal Biochem       Date:  2003-04-01       Impact factor: 3.365

8.  Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.

Authors:  F Pendino; M Flexor; F Delhommeau; D Buet; M Lanotte; E Segal-Bendirdjian
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

9.  Real-time quantitative analysis of telomerase activity in breast tumor specimens using a highly specific and sensitive fluorescent-based assay.

Authors:  Lynne W Elmore; Heidi L Forsythe; Andrea Ferreira-Gonzalez; Carleton T Garrett; Gary M Clark; Shawn E Holt
Journal:  Diagn Mol Pathol       Date:  2002-09

10.  Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms.

Authors:  D Xu; A Gruber; M Björkholm; C Peterson; P Pisa
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

View more
  7 in total

1.  The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis.

Authors:  Chu-Fang Chou; Yu-Hua Hsieh; Clinton J Grubbs; Venkatram R Atigadda; James A Mobley; Reinhard Dummer; Donald D Muccio; Isao Eto; Craig A Elmets; W Timothy Garvey; Pi-Ling Chang
Journal:  J Dermatol Sci       Date:  2018-03-15       Impact factor: 4.563

2.  The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells.

Authors:  Jenny M Whitworth; Angelina I Londoño-Joshi; Jeffrey C Sellers; Patsy J Oliver; Donald D Muccio; Venkatram R Atigadda; J Michael Straughn; Donald J Buchsbaum
Journal:  Gynecol Oncol       Date:  2011-12-09       Impact factor: 5.482

3.  A pilot, first-in-human, pharmacokinetic study of 9cUAB30 in healthy volunteers.

Authors:  Jill M Kolesar; Ryan Hoel; Marcia Pomplun; Tom Havighurst; Jeanne Stublaski; Barbara Wollmer; Helen Krontiras; Wayne Brouillette; Donald Muccio; Kyungmann Kim; Clinton J Grubbs; Howard E Bailey
Journal:  Cancer Prev Res (Phila)       Date:  2010-12

4.  Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation.

Authors:  Samantha L Martin; Rishabh Kala; Trygve O Tollefsbol
Journal:  Curr Cancer Drug Targets       Date:  2018       Impact factor: 3.428

5.  Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid.

Authors:  Wen Jiang; Wentao Deng; Sarah K Bailey; Clint D Nail; Andra R Frost; Wayne J Brouillette; Donald D Muccio; Clinton J Grubbs; J Michael Ruppert; Susan M Lobo-Ruppert
Journal:  Cancer Biol Ther       Date:  2009-02-21       Impact factor: 4.742

6.  A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers.

Authors:  Jill M Kolesar; Shannon Andrews; Heather Green; Tom C Havighurst; Barbara W Wollmer; Katina DeShong; Douglas E Laux; Helen Krontiras; Donald D Muccio; KyungMann Kim; Clinton J Grubbs; Margaret G House; Howard L Parnes; Brandy M Heckman-Stoddard; Howard H Bailey
Journal:  Cancer Prev Res (Phila)       Date:  2019-09-04

7.  Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.

Authors:  Rishabh Kala; Harsh N Shah; Samantha L Martin; Trygve O Tollefsbol
Journal:  BMC Cancer       Date:  2015-10-12       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.